Newsroom

July 23, 2024

This author wrote a children's book about family medical history after discovering gene mutation

Read more
July 19, 2024

Stressed about politics? Here are 5 ways to take care of your mental health

Read more
August 29, 2024

14 Old Wives' Tales Used to Predict a Baby's Gender That Have Been Debunked

Read more
June 7, 2024

Genetic Risk Score Revolutionizes TNBC Prediction in Black Women

Read more
previous slide
    next slide

    Scientific publications

    See all

    High positive predictive value 22q11.2 microdeletion screening by prenatal cell-free DNA testing that incorporates fetal fraction amplification

    Read publication
    NPWH 2023

    Menopausal symptom management considerations in patients at high risk for breast cancer

    Read publication
    AUA Western 2023

    Active surveillance selection and durability in men with NCCN intermediate-risk, localized prostate cancer...

    SMFM 2024

    High positive predictive value of 22q11.2 microdeletion screening by prenatal cell-free DNA testing that...

    Read more
    ASCO 2024

    Improving a Polygenic Risk Score (PRS) for breast cancer (BC) risk assessment in diverse ancestries

    Read more
    previous slide
      next slide

      Press releases

      See all

      Oct 03, 2024

      Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics

      Read more

      Oct 01, 2024

      Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

      Read more

      Sep 18, 2024

      Myriad Genetics to Share New Data Highlighting Genetic Testing Advancements at 2024 National Society of Genetic Counselors Annual Conference

      Read more

      Sep 05, 2024

      Myriad Genetics to Host Investor Event on October 9, 2024

      Read more

      Public relations contacts

      Glenn Farrell, Kate Schraml, Megan Manzari

      pr@myriad.com

      Investor relations contacts

      Matt Scalo

      ir@myriad.com
      X social media icon Linkedin social media icon

      About Myriad Genetics

      Myriad Genetics is a leader in genetic testing and precision medicine, providing insights that help people take control of their health and enable healthcare providers to better detect, treat and prevent disease. 

      • Early insights helped Ashley prepare

        “Carrier screening empowers you to make the right decisions. Not only are you making a decision for yourself right now but you’re making a decision for the next 80, 90, 100 years to create a better life for you and your baby.”
        Watch Ashley's story

      • Prenatal screening gave Hannah time to plan

        “Once we got the noninvasive prenatal screening results back, we were able to meet with a lot more physicians.”

      • How Prolaris provided clarity for his prostate cancer treatment plan

        “Prolaris gave me the ability to maintain the lifestyle that my wife and I have lived with for many years now.”
        Watch Tim's story
      previous slide
        next slide